HYPNONAG : Therapeutic Communication Versus Traditional Method for Naso-gastric Intubation in Haematology
Launched by RENNES UNIVERSITY HOSPITAL · Mar 16, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The HYPNONAG trial is studying a new way to help patients with blood cancers who need a special tube called a nasogastric tube (NGS) to receive nutrition during their hospital stay. This trial compares two methods: one where a nurse uses hypnosis to help patients place the tube themselves, and the traditional method where caregivers insert the tube. The goal is to see if using hypnosis makes the process less stressful and more comfortable for patients, allowing them to take part in their own care.
To participate in this study, you need to be an adult (18 years or older) who is currently in the hospital for chemotherapy and requires an NGS to help with feeding. You should be able to give your consent and not have any conditions that would make it difficult for you to participate, such as severe mental health issues or being in end-of-life care. If you join the trial, you can expect to learn how to insert the NGS on your own, with the support of a nurse trained in hypnosis, which aims to make the experience more manageable and less invasive. This trial is currently recruiting participants, and your involvement could help improve care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient hospitalized for chemotherapy generating an aplasia lasting more than 8 days (hospitalization for 3 weeks) and for whom the insertion of an NGS is required and not yet attempted since admission to the hospital;
- • Age ≥ 18 years;
- • Affiliated to a social security scheme;
- • Having signed a free, informed and written consent.
- Exclusion Criteria:
- • Pregnant or breastfeeding women;
- • Patient who refuses NGS;
- • Emergency surgery;
- • Patients consuming long-term opiates before surgery;
- • Substance addiction;
- • Patient at the end of life and/or in palliative care;
- • Patient unable to answer a questionnaire and/or unable to understand the rating scales;
- • Deaf and/or dumb patients;
- • Patients with psychiatric pathologies (schizophrenia, bipolarity);
- • Persons subject to legal protection (safeguard of justice, curatorship, guardianship), persons deprived of liberty.
About Rennes University Hospital
Rennes University Hospital, a leading academic medical center in France, is dedicated to advancing healthcare through innovative clinical research and trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific research with clinical practice, fostering collaboration among multidisciplinary teams. Its commitment to excellence is reflected in its robust infrastructure and expertise in various medical fields, enabling the development and evaluation of novel therapies and treatment protocols. By participating in clinical trials, Rennes University Hospital aims to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rennes, Bretagne, France
Tours, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials